| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |